Global Small Molecule CMO Market: Size, Trends & Forecasts (2019-2023)
SCOPE OF THE REPORT
The report entitled “Global Small Molecule CMO Market: Size, Trends & Forecasts (2019-2023)”, provides an analysis of the global small molecule CMO market with market sizing and growth. The analysis includes market size in terms of value, market share by segments, and by region. A brief segment analysis of small molecule CMO market has also been provided. Moreover, an overview of pharmaceutical industry and contract manufacturing industry has included in the report.
The report also assesses the key opportunities available in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the small molecule CMO market has forecasted for the period 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The small molecule CMO market is highly fragmented, as the top ten players accounted for less than half market share globally. Lonza Group, Wuxi AppTec Co., Ltd., Catalent, Inc., and Patheon Inc. are key companies in the global market whose company profiling has been done in the report. This segment of the report provides business overview, financial overview, and business strategies adopted by the respective companies.
Company Coverage
The pharmaceutical industry primarily encompassed a large number of private as well as public organizations that discover, develop, produce, and market drugs for medicinal use. It is considered as one of the vital component of health care system worldwide. On the basis of molecule types, pharmaceutical drugs can be categorized into small molecule or conventional drugs, and large molecules or biologic drugs.
Small molecules are primarily made up of naturally occurring compounds which have been isolated or re-synthesized in the laboratory. These are interchangeably called as drugs. Majority of drugs are come under the category of small molecules. Small molecules are well defined, and independent of manufacturing process.
CMO or Contract Manufacturing Organization is a third party, which the pharmaceutical firms approach for the manufacturing of components of its product or whole of its product. A contract manufacturing organization (CMO) undertakes the production of product(s) under the brand name of another firm. Sometimes CMOs are also referred as contract development and manufacturing organization (CDMO).
The global small molecule CMO market has shown upward trends over the past few years and projections are made that the market would follow the same trends in the next five years (2019-2023) as well. The market is expected to grow at a significant growth rate over the forecasted period. Growing pharmaceutical industry and rising demand for oncology drugs are the major factors that are driving the growth of the market. Other growth drivers such as growing demand for process development CMO services, robust pipeline of small molecule drugs & increasing rate of FDA approvals, mergers & acquisitions, growing demand for CDMOs offering highly potent API etc. are expected to boost the growth of the market in the near future.
The report entitled “Global Small Molecule CMO Market: Size, Trends & Forecasts (2019-2023)”, provides an analysis of the global small molecule CMO market with market sizing and growth. The analysis includes market size in terms of value, market share by segments, and by region. A brief segment analysis of small molecule CMO market has also been provided. Moreover, an overview of pharmaceutical industry and contract manufacturing industry has included in the report.
The report also assesses the key opportunities available in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the small molecule CMO market has forecasted for the period 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The small molecule CMO market is highly fragmented, as the top ten players accounted for less than half market share globally. Lonza Group, Wuxi AppTec Co., Ltd., Catalent, Inc., and Patheon Inc. are key companies in the global market whose company profiling has been done in the report. This segment of the report provides business overview, financial overview, and business strategies adopted by the respective companies.
Company Coverage
- Lonza Group
- Wuxi AppTec Co., Ltd
- Catalent, Inc.
- Patheon Inc.
- The U.S
- China
The pharmaceutical industry primarily encompassed a large number of private as well as public organizations that discover, develop, produce, and market drugs for medicinal use. It is considered as one of the vital component of health care system worldwide. On the basis of molecule types, pharmaceutical drugs can be categorized into small molecule or conventional drugs, and large molecules or biologic drugs.
Small molecules are primarily made up of naturally occurring compounds which have been isolated or re-synthesized in the laboratory. These are interchangeably called as drugs. Majority of drugs are come under the category of small molecules. Small molecules are well defined, and independent of manufacturing process.
CMO or Contract Manufacturing Organization is a third party, which the pharmaceutical firms approach for the manufacturing of components of its product or whole of its product. A contract manufacturing organization (CMO) undertakes the production of product(s) under the brand name of another firm. Sometimes CMOs are also referred as contract development and manufacturing organization (CDMO).
The global small molecule CMO market has shown upward trends over the past few years and projections are made that the market would follow the same trends in the next five years (2019-2023) as well. The market is expected to grow at a significant growth rate over the forecasted period. Growing pharmaceutical industry and rising demand for oncology drugs are the major factors that are driving the growth of the market. Other growth drivers such as growing demand for process development CMO services, robust pipeline of small molecule drugs & increasing rate of FDA approvals, mergers & acquisitions, growing demand for CDMOs offering highly potent API etc. are expected to boost the growth of the market in the near future.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Pharmaceutical Industry Overview
2.1.1 Segmentation of Pharmaceutical Industry (Drugs)
2.1.2 Small Molecule vs Biological Drugs
2.2 Drug Manufacturing Process
2.2.1 Drug Manufacturing Process
2.2.2 Comparison: In-House Vs CMO Production
3. GLOBAL MARKET ANALYSIS
3.1 Global Pharmaceutical Market Analysis
3.1.1 Global Pharmaceutical Market by Value
3.1.2 Global Pharmaceutical Market by Molecule-Type
3.1.3 Global Small Molecule Market by Value
3.2 Global Pharmaceutical Manufacturing Market Analysis
3.2.1 Global Pharmaceutical Manufacturing Market by Value
3.2.2 Global Pharmaceutical Manufacturing Market by Production
3.3 Global Small Molecule CMO Market Analysis
3.3.1 Global Outsourced/CMO Market by Value
3.3.2 Global Outsourced/CMO Market by Molecule-Type
3.3.3 Global Small Molecule CMO Market by Value
3.3.4 Global Small Molecule CMO Market by Segments (Originator Drugs, Generic Drugs)
3.3.5 Global Small Molecule CMO Market by Region
3.4 Global Small Molecule CMO Market: Segment Analysis
3.4.1 Global Small Molecule CMO Generic Drug Market by Value
3.4.2 Global Small Molecule CMO Originator Drug Market by Value
4. REGIONAL ANALYSIS
4.1 The U.S. Small Molecule CMO Market Analysis
4.1.1 The U.S. Small Molecule CMO Market by Value
4.2 China Small Molecule CMO Market Analysis
4.2.1 China Small Molecule CMO Market by Value
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Global Pharmaceutical Industry Growth
5.1.2 Growing Demand for Oncology Drugs
5.1.3 Growing Demand for Process Development CMO Services
5.1.4 Low Manufacturing Cost
5.1.5 Robust Pipeline of Small Molecule Drugs and Increasing Rate of FDA Approvals
5.2 Challenges
5.2.1 Risk Associated with CMOs
5.2.2 Stringent Regulations
5.2.3 Technical Challenges
5.2.4 Intellectual Property Risks and Quality Issues
5.3 Market Trends
5.3.1 Entrance of Numerous Small, Virtual Startups
5.3.2 Increasing Complexity of Small Molecule Drugs
5.3.3 Mergers & Acquisitions
5.3.4 Growing Demand for CDMOs Offering Highly Potent API
5.3.5 Capacity Utilization Rate of CMO Industry
6. COMPETITIVE LANDSCAPE
6.1 Global Small Molecule CMO Market by Players
7. COMPANY PROFILES
7.1 Lonza Group
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Wuxi AppTec Co., Ltd
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Catalent, Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Patheon Inc.
7.4.1 Business Overview
7.4.2 Business Strategy
2. INTRODUCTION
2.1 Pharmaceutical Industry Overview
2.1.1 Segmentation of Pharmaceutical Industry (Drugs)
2.1.2 Small Molecule vs Biological Drugs
2.2 Drug Manufacturing Process
2.2.1 Drug Manufacturing Process
2.2.2 Comparison: In-House Vs CMO Production
3. GLOBAL MARKET ANALYSIS
3.1 Global Pharmaceutical Market Analysis
3.1.1 Global Pharmaceutical Market by Value
3.1.2 Global Pharmaceutical Market by Molecule-Type
3.1.3 Global Small Molecule Market by Value
3.2 Global Pharmaceutical Manufacturing Market Analysis
3.2.1 Global Pharmaceutical Manufacturing Market by Value
3.2.2 Global Pharmaceutical Manufacturing Market by Production
3.3 Global Small Molecule CMO Market Analysis
3.3.1 Global Outsourced/CMO Market by Value
3.3.2 Global Outsourced/CMO Market by Molecule-Type
3.3.3 Global Small Molecule CMO Market by Value
3.3.4 Global Small Molecule CMO Market by Segments (Originator Drugs, Generic Drugs)
3.3.5 Global Small Molecule CMO Market by Region
3.4 Global Small Molecule CMO Market: Segment Analysis
3.4.1 Global Small Molecule CMO Generic Drug Market by Value
3.4.2 Global Small Molecule CMO Originator Drug Market by Value
4. REGIONAL ANALYSIS
4.1 The U.S. Small Molecule CMO Market Analysis
4.1.1 The U.S. Small Molecule CMO Market by Value
4.2 China Small Molecule CMO Market Analysis
4.2.1 China Small Molecule CMO Market by Value
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Global Pharmaceutical Industry Growth
5.1.2 Growing Demand for Oncology Drugs
5.1.3 Growing Demand for Process Development CMO Services
5.1.4 Low Manufacturing Cost
5.1.5 Robust Pipeline of Small Molecule Drugs and Increasing Rate of FDA Approvals
5.2 Challenges
5.2.1 Risk Associated with CMOs
5.2.2 Stringent Regulations
5.2.3 Technical Challenges
5.2.4 Intellectual Property Risks and Quality Issues
5.3 Market Trends
5.3.1 Entrance of Numerous Small, Virtual Startups
5.3.2 Increasing Complexity of Small Molecule Drugs
5.3.3 Mergers & Acquisitions
5.3.4 Growing Demand for CDMOs Offering Highly Potent API
5.3.5 Capacity Utilization Rate of CMO Industry
6. COMPETITIVE LANDSCAPE
6.1 Global Small Molecule CMO Market by Players
7. COMPANY PROFILES
7.1 Lonza Group
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Wuxi AppTec Co., Ltd
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Catalent, Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Patheon Inc.
7.4.1 Business Overview
7.4.2 Business Strategy
LIST OF FIGURES
Figure 1: History of Pharmaceutical Industry
Figure 2: Pharmaceutical Industry Segments
Figure 3: Drug Manufacturing Process
Figure 4: Global Pharmaceutical Market by Value; 2014-2018 (US$ Trillion)
Figure 5: Global Pharmaceutical Market by Value; 2019-2023E (US$ Trillion)
Figure 6: Global Pharmaceutical Market by Molecule-Type; 2018
Figure 7: Global Small Molecule Market by Value; 2017-2018 (US$ Billion)
Figure 8: Global Small Molecule Market by Value; 2019-2023E (US$ Billion)
Figure 9: Global Pharmaceutical Manufacturing Market by Value; 2017-2018 (US$ Billion)
Figure 10: Global Pharmaceutical Manufacturing Market by Value; 2019-2023E (US$ Billion)
Figure 11: Global Pharmaceutical Drug Manufacturing Market by Production; 2018
Figure 12: Global Outsourced/CMO Market by Value; 2017-2018 (US$ Billion)
Figure 13: Global Outsourced/CMO Market by Value; 2019-2023E (US$ Billion)
Figure 14: Global Outsourced/CMO Market by Molecule-Type; 2018
Figure 15: Global Small Molecule CMO Market by Value; 2017-2018 (US$ Billion)
Figure 16: Global Small Molecule CMO Market by Value; 2019-2023E (US$ Billion)
Figure 17: Global Small Molecule CMO Market by Segments; 2018
Figure 18: Global Small Molecule CMO Market by Region; 2018
Figure 19: Global Small Molecule CMO Generic Drug Market by Value; 2017-2018 (US$ Billion)
Figure 20: Global Small Molecule CMO Generic Drug Market by Value; 2019-2023E (US$ Billion)
Figure 21: Global Small Molecule CMO Originator Drug Market by Value; 2017-2018 (US$ Billion)
Figure 22: Global Small Molecule CMO Originator Drug Market by Value; 2019-2023E (US$ Billion)
Figure 23: The U.S. Small Molecule CMO Market by Value; 2014-2018 (US$ Billion)
Figure 24: The U.S. Small Molecule CMO Market by Value; 2019-2023E (US$ Billion)
Figure 25: China Small Molecule CMO Market by Value; 2014-2018 (US$ Billion)
Figure 26: China Small Molecule CMO Market by Value; 2019-2023E (US$ Billion)
Figure 27: Global Pharmaceutical Industry by Value; 2016-2023 (US$ Trillion)
Figure 28: Global Oncology Drugs Market; 2017-2023 (US$ Billion) 2010-2017
Figure 29: Capacity Utilization Rate of the Global CMO Industry; 2014-2020 (%)
Figure 30: Global Small Molecule CMO Market by Players; 2018
Figure 31: Lonza Group Sales; 2014-2018 (US$ Billion)
Figure 32: Lonza Group Sales by Segments; 2018
Figure 33: Wuxi AppTec Co., Ltd & CMO Services Revenue; 2015-2017 (US$ Million)
Figure 34: Wuxi AppTec Co., Ltd Revenue by Segments; 2017
Figure 35: Catalent, Inc. Revenue; 2014-2018 (US$ Billion)
Figure 36: Catalent, Inc. Revenue by Segments; 2018
Table 1: Characteristics of Small Molecule Drugs Compared to Biologicals
Table 2: Comparison: In-House Vs CMO Production
Table 3: Small Molecule and Biologics New Molecular Entities Approved by FDA, 2010-2017
Figure 1: History of Pharmaceutical Industry
Figure 2: Pharmaceutical Industry Segments
Figure 3: Drug Manufacturing Process
Figure 4: Global Pharmaceutical Market by Value; 2014-2018 (US$ Trillion)
Figure 5: Global Pharmaceutical Market by Value; 2019-2023E (US$ Trillion)
Figure 6: Global Pharmaceutical Market by Molecule-Type; 2018
Figure 7: Global Small Molecule Market by Value; 2017-2018 (US$ Billion)
Figure 8: Global Small Molecule Market by Value; 2019-2023E (US$ Billion)
Figure 9: Global Pharmaceutical Manufacturing Market by Value; 2017-2018 (US$ Billion)
Figure 10: Global Pharmaceutical Manufacturing Market by Value; 2019-2023E (US$ Billion)
Figure 11: Global Pharmaceutical Drug Manufacturing Market by Production; 2018
Figure 12: Global Outsourced/CMO Market by Value; 2017-2018 (US$ Billion)
Figure 13: Global Outsourced/CMO Market by Value; 2019-2023E (US$ Billion)
Figure 14: Global Outsourced/CMO Market by Molecule-Type; 2018
Figure 15: Global Small Molecule CMO Market by Value; 2017-2018 (US$ Billion)
Figure 16: Global Small Molecule CMO Market by Value; 2019-2023E (US$ Billion)
Figure 17: Global Small Molecule CMO Market by Segments; 2018
Figure 18: Global Small Molecule CMO Market by Region; 2018
Figure 19: Global Small Molecule CMO Generic Drug Market by Value; 2017-2018 (US$ Billion)
Figure 20: Global Small Molecule CMO Generic Drug Market by Value; 2019-2023E (US$ Billion)
Figure 21: Global Small Molecule CMO Originator Drug Market by Value; 2017-2018 (US$ Billion)
Figure 22: Global Small Molecule CMO Originator Drug Market by Value; 2019-2023E (US$ Billion)
Figure 23: The U.S. Small Molecule CMO Market by Value; 2014-2018 (US$ Billion)
Figure 24: The U.S. Small Molecule CMO Market by Value; 2019-2023E (US$ Billion)
Figure 25: China Small Molecule CMO Market by Value; 2014-2018 (US$ Billion)
Figure 26: China Small Molecule CMO Market by Value; 2019-2023E (US$ Billion)
Figure 27: Global Pharmaceutical Industry by Value; 2016-2023 (US$ Trillion)
Figure 28: Global Oncology Drugs Market; 2017-2023 (US$ Billion) 2010-2017
Figure 29: Capacity Utilization Rate of the Global CMO Industry; 2014-2020 (%)
Figure 30: Global Small Molecule CMO Market by Players; 2018
Figure 31: Lonza Group Sales; 2014-2018 (US$ Billion)
Figure 32: Lonza Group Sales by Segments; 2018
Figure 33: Wuxi AppTec Co., Ltd & CMO Services Revenue; 2015-2017 (US$ Million)
Figure 34: Wuxi AppTec Co., Ltd Revenue by Segments; 2017
Figure 35: Catalent, Inc. Revenue; 2014-2018 (US$ Billion)
Figure 36: Catalent, Inc. Revenue by Segments; 2018
Table 1: Characteristics of Small Molecule Drugs Compared to Biologicals
Table 2: Comparison: In-House Vs CMO Production
Table 3: Small Molecule and Biologics New Molecular Entities Approved by FDA, 2010-2017
